EUVIMEDEUVIMED entdecken
Crossref

Etiological and clinical characteristics of childhood hypertransaminasemia: a retrospective study

Demet Teker Düztaş, Aydın Bozkaya

Turkish Journal of Clinics and Laboratory · 29.03.2026 · (1)

DOI: 10.18663/tjcl.1832567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Clinics and Laboratory, online erschienen am 29.03.2026. Verfasst von Demet Teker Düztaş und 1 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Gefördert von: This study received no financial support from any person or institution..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This the study aimed to describe the etiologic distribution, clinical characteristics, and outcomes of hypertransaminasemia in children.Material and Methods: This retrospective cohort study was conducted using electronic medical records of children aged 1 month–18 years who presented with persistent transaminase elevation between January 2023 and July 2024. Hypertransaminasemia was defined as alanine aminotransferase (ALT) >45 IU/L and/or aspartate aminotransferase (AST) >50 IU/L on at least two measurements with elevation persisting for at least 3 months. Patients with extrahepatic cholestasis or insufficient data were excluded. Demographic, clinical, laboratory, and imaging findings were collected, and etiologies were categorized. Subgroup analyses were performed based on cholestasis and ALT >10× the upper limit of normal (ULN).

Results

Among 6886 first-time clinic visits, 214 children (3.1%) met the inclusion criteria. The cohort was predominantly male (55.6%) with a median age of 2.3 years, and parental consanguinity was notably high (79.9%). Infectious causes accounted for the majority of cases (65%), while metabolic/genetic disorders (9.3%), drug-induced liver injury (7%), metabolic dysfunction–associated steatotic liver disease (MASLD) (3.3%), and autoimmune disease (1.4%) were less frequent; 14% remained idiopathic. ALT >10×ULN was observed in 20.6% of patients, and cholestasis in 25.7%. Although these subgroups showed higher biochemical abnormalities, their etiologic patterns and normalization times were similar to the overall cohort. Follow-up data were available for 172 patients (80.4%); among them, transaminase levels normalized in 128 (74.4%), with a median time to normalization of 37.5 days (IQR 26.6–70).

Conclusion

Hypertransaminasemia appears to be strongly influenced by regional factors, and establishing standardized pediatric reference ranges in Türkiye would substantially improve diagnostic accuracy.

Förderung

  • This study received no financial support from any person or institution.

Zitieren

APA

Düztaş, D. T., & Bozkaya, A. (2026). Etiological and clinical characteristics of childhood hypertransaminasemia: a retrospective study. Turkish Journal of Clinics and Laboratory. https://doi.org/10.18663/tjcl.1832567

Vancouver

Düztaş DT, Bozkaya A. Etiological and clinical characteristics of childhood hypertransaminasemia: a retrospective study. Turkish Journal of Clinics and Laboratory. 2026. doi:10.18663/tjcl.1832567

BibTeX
@article{Dzta2026,
  author = {Düztaş, Demet Teker and Bozkaya, Aydın},
  title = {Etiological and clinical characteristics of childhood hypertransaminasemia: a retrospective study},
  journal = {Turkish Journal of Clinics and Laboratory},
  year = {2026},
  number = {1},
  doi = {10.18663/tjcl.1832567}
}
Kostenlos starten →